106 related articles for article (PubMed ID: 17272247)
1. Another bleeding heart: perioperative heparin management revisited.
Harle CC; Murkin JM
Can J Anaesth; 2007 Feb; 54(2):97-102. PubMed ID: 17272247
[No Abstract] [Full Text] [Related]
2. Preoperative low molecular weight heparin reduces heparin responsiveness during cardiac surgery.
Bar-Yosef S; Cozart HB; Phillips-Bute B; Mathew JP; Grocott HP
Can J Anaesth; 2007 Feb; 54(2):107-13. PubMed ID: 17272249
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of platelet-dependent thrombosis by low molecular weight heparin (CY222): comparison with standard heparin.
Cadroy Y; Harker LA; Hanson SR
J Lab Clin Med; 1989 Oct; 114(4):349-57. PubMed ID: 2551985
[TBL] [Abstract][Full Text] [Related]
4. Heparin and low molecular weight heparin in thrombosis and beyond.
Mousa SA
Curr Opin Investig Drugs; 2002 Aug; 3(8):1181-6. PubMed ID: 12211411
[TBL] [Abstract][Full Text] [Related]
5. Does preoperative level of antithrombin III predict heparin resistance during extracorporeal circulation?
Rodríguez-López JM; del Barrio E; Lozano FS; Muriel C
Anesth Analg; 2008 Oct; 107(4):1444-5. PubMed ID: 18806070
[No Abstract] [Full Text] [Related]
6. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
[TBL] [Abstract][Full Text] [Related]
7. Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass.
Guzzetta NA; Monitz HG; Fernandez JD; Fazlollah TM; Knezevic A; Miller BE
Anesth Analg; 2010 Jul; 111(1):173-9. PubMed ID: 20519414
[TBL] [Abstract][Full Text] [Related]
8. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
Melo FR; Mourão PA
Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective.
Hull RD; Raskob GE; Pineo GF; Feldstein W; Rosenbloom D; Gafni A; Green D; Feinglass J; Trowbridge AA; Elliott CG
Arch Intern Med; 1997 Feb; 157(3):298-303. PubMed ID: 9040296
[TBL] [Abstract][Full Text] [Related]
10. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
[TBL] [Abstract][Full Text] [Related]
11. Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.
Pleym H; Videm V; Wahba A; Asberg A; Amundsen T; Bjella L; Dale O; Stenseth R
Eur J Cardiothorac Surg; 2006 Jun; 29(6):933-40. PubMed ID: 16675258
[TBL] [Abstract][Full Text] [Related]
12. [Comparative analysis of unfractionated and low molecular weight heparins on the polymerization process of fibrin].
Barkagan ZS; Solomina TA
Biull Eksp Biol Med; 1997 Sep; 124(9):346-7. PubMed ID: 9445624
[No Abstract] [Full Text] [Related]
13. Pravastatin potentiates the anticoagulant effects of low molecular weight heparin.
Zimmer JE; Spillert CR; Puppala S; Zamecki K; Bhatt BA; Arora RR
Thromb Res; 2004; 113(6):407-10. PubMed ID: 15226096
[TBL] [Abstract][Full Text] [Related]
14. Heparinless cardiopulmonary bypass revisited: a newer strategy to avoid heparin-related bleeding using dermatan sulfate.
Brister SJ; Buchanan MR
J Cardiothorac Vasc Anesth; 1995 Jun; 9(3):317-21. PubMed ID: 7669967
[No Abstract] [Full Text] [Related]
15. Overview: from heparin to low molecular weight heparin: beyond anticoagulation.
Mousa SA; Fareed J
Curr Opin Investig Drugs; 2001 Aug; 2(8):1077-80. PubMed ID: 11892916
[No Abstract] [Full Text] [Related]
16. [Anticoagulation for plasmapheresis].
Amemiya H; Sekihara H; Kobayashi T; Koiwa F; Niikura K
Nihon Rinsho; 2004 May; 62 Suppl 5():323-7. PubMed ID: 15197938
[No Abstract] [Full Text] [Related]
17. Prevention of catheter-related thrombosis after cardiac surgery: Is heparin the answer?
Meyer AD; Jacobs BR
Pediatr Crit Care Med; 2010 Jul; 11(4):531-2. PubMed ID: 20606557
[No Abstract] [Full Text] [Related]
18. Management of deep vein thrombosis in cancer patients.
Jahanzeb M
J Natl Compr Canc Netw; 2005 Nov; 3 Suppl 1():S50-3. PubMed ID: 16280114
[No Abstract] [Full Text] [Related]
19. Heparin resistance during cardiopulmonary bypass.
Jung HJ; Kim JB; Im KS; Oh SH; Lee JM
J Cardiovasc Med (Hagerstown); 2009 Dec; 10(12):940-1. PubMed ID: 19617851
[TBL] [Abstract][Full Text] [Related]
20. Comparison of fondaparinux, low molecular-weight heparin and unfractionated heparin in preventing thrombus formation on mechanical heart valves: results of an in-vitro study.
Schlitt A; Hamilton K; Maegdefessel L; Dahm M; Theis C; Eichler M; Brockmann O; Steinseifer U; Hauroeder B; Hitzler WE; Rupprecht HJ
J Heart Valve Dis; 2006 Nov; 15(6):809-14. PubMed ID: 17152789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
